A comprehensive view of Immune System Health. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Fitch affirms Amgen's issuer default rating at BBB+ with stable rating outlook, says ChemoCentryx acquisition makes strategic sense, as it adds to Amgen's current presence in autoimmune diseases, inflammatory disorders and cancer

Roche launches new Elecsys IGRA diagnostic test that detects T-cell response to determine immune response to SARS-CoV-2 in countries that accept the CE Mark; test intended to guide clinical care for immunocompromised and high-risk patients

Gilead acquiring MiroBio for US$405.0M; acquisition gives Gilead access to MiroBio’s proprietary discovery platform and entire portfolio of immune inhibitory receptor agonists

GentiBio collaborating with Bristol Myers to develop engineered T cell therapies to re-establish immune tolerance, repair tissue in inflammatory bowel disease patients; collaboration to produce disease-specific Tregs, take programs into clinical trials

Teva swings to Q2 GAAP net loss of US$232.0M from net profit of US$207.0M a year ago, with net revenue down at US$3.8B from US$3.9B a year ago; Capaxone sales lower than expected at US$700.0M due to increased competition, foreign exchange rates

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count